Location History:
- S San Francisco, CA (US) (1998)
- S. San Francisco, CA (US) (1999)
- South San Francisco, CA (US) (1998 - 2001)
Company Filing History:
Years Active: 1998-2001
Certainly! Here is the article about inventor Ning Zhang:
Title: Innovator Spotlight: Ning Zhang - Pioneering Metabolic Regulation through UCP3 Inventions
Introduction:
Ning Zhang, a distinguished inventor based in South San Francisco, CA, has made significant contributions to the field of metabolic regulation through his pioneering work on UCP3 genes. With a portfolio boasting six patents, Ning Zhang stands as a trailblazer in the biopharmaceutical industry.
Latest Patents:
Ning Zhang's latest patents revolve around UCP3 genes, focusing on methods and compositions related to a novel family of UCP3 polypeptides and associated nucleic acids crucial in metabolic regulation. These patents encompass innovative techniques for the production of mUCP3 polypeptides, hybridization probes, knock-out/in constructs, and primers essential for specific hybridization and manipulation of mUCP3 genes.
Career Highlights:
Currently affiliated with Tularik Limited, a renowned biopharmaceutical company, Ning Zhang continues to drive innovation in metabolic research. His groundbreaking inventions have paved the way for advancements in biopharmaceuticals, solidifying his reputation as a leading figure in the industry.
Collaborations:
Ning Zhang's impactful work has been enriched through collaborations with esteemed colleagues such as Jin-Long Chen and M Catherine Amaral. Together, they have synergized their expertise to push the boundaries of metabolic research and usher in a new era of scientific discovery.
Conclusion:
In conclusion, Ning Zhang's groundbreaking inventions in the realm of UCP3 genes underscore his commitment to advancing metabolic regulation and biopharmaceutical innovation. His legacy serves as an inspiration for aspiring inventors and researchers, setting a high standard for excellence in the field.